Name | cidofovir dihydrate |
---|---|
Synonyms |
Cidofovir hydrate (1:2)
Gs-0504 Phosphonic acid, [[(1S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]- Cidofovir dihydrate ({[(2S)-1-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid Cidofovir (S)-[[2-(4-Amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]phosphonic Acid Unii-jil713Q00n (S)-HPMPC Hydrate Cidovir Hydrate Vistide Hydrate (S)-2-(4-Amino-2-oxo-1(2H)-pyrimidinyl-1-(hydroxymethyl)ethoxy)methyl phosphonic acid ({[(2S)-1-(4-Amino-2-oxo-1(2H)-pyrimidinyl)-3-hydroxy-2-propanyl]oxy}methyl)phosphonic acid Vistide Drg-0145 Cidofovir hydrate GS 0504 Hydrate Cidofovir (dihydrate) |
Description | Cidofovir dehydrate is an injectable antiviral medication for the treatment of cytomegalovirus (CMV) retinitis, which suppresses virus replication by selective inhibition of viral DNA synthesis.Target: CMV DNA polymeraseCidofovir is an injectable antiviral medication for the treatment of cytomegalovirus (CMV) retinitis in patients with AIDS. It suppresses CMV replication by selective inhibition of viral DNA polymerase and therefore prevention of viral replication and transcription. It is an acyclic nucleoside phosphonate, and is therefore independent of phosphorylation by viral enzymes, unlike acyclovir.Cidofovir was discovered at the Institute of Organic Chemistry and Biochemistry, Prague, by Antonín Hol?, and developed by Gilead Sciences and is marketed with the brand name Vistide by Gilead in the USA, and by Pfizer elsewhere. Maintenance therapy with cidofovir involves an infusion only once every two weeks, making it a convenient treatment option. Because dosing is relatively infrequent, a permanent catheter is not necessary for infusions. |
---|---|
Related Catalog | |
References |
Density | 1.8±0.1 g/cm3 |
---|---|
Boiling Point | 609.5±65.0 °C at 760 mmHg |
Melting Point | 260ºC (dec) |
Molecular Formula | C8H18N3O8P |
Molecular Weight | 315.22 |
Flash Point | 322.4±34.3 °C |
PSA | 157.71000 |
LogP | -3.37 |
Vapour Pressure | 0.0±4.0 mmHg at 25°C |
Index of Refraction | 1.656 |